|
Atomistry » Zinc » PDB 6kak-6km2 » 6kj8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Zinc » PDB 6kak-6km2 » 6kj8 » |
Zinc in PDB 6kj8: E. Coli Atcase Holoenzyme Mutant - G166P (Catalytic Chain)Enzymatic activity of E. Coli Atcase Holoenzyme Mutant - G166P (Catalytic Chain)
All present enzymatic activity of E. Coli Atcase Holoenzyme Mutant - G166P (Catalytic Chain):
2.1.3.2; Protein crystallography data
The structure of E. Coli Atcase Holoenzyme Mutant - G166P (Catalytic Chain), PDB code: 6kj8
was solved by
Z.Lei,
J.Zheng,
Z.C.Jia,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Zinc Binding Sites:
The binding sites of Zinc atom in the E. Coli Atcase Holoenzyme Mutant - G166P (Catalytic Chain)
(pdb code 6kj8). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 3 binding sites of Zinc where determined in the E. Coli Atcase Holoenzyme Mutant - G166P (Catalytic Chain), PDB code: 6kj8: Jump to Zinc binding site number: 1; 2; 3; Zinc binding site 1 out of 3 in 6kj8Go back to Zinc Binding Sites List in 6kj8
Zinc binding site 1 out
of 3 in the E. Coli Atcase Holoenzyme Mutant - G166P (Catalytic Chain)
Mono view Stereo pair view
Zinc binding site 2 out of 3 in 6kj8Go back to Zinc Binding Sites List in 6kj8
Zinc binding site 2 out
of 3 in the E. Coli Atcase Holoenzyme Mutant - G166P (Catalytic Chain)
Mono view Stereo pair view
Zinc binding site 3 out of 3 in 6kj8Go back to Zinc Binding Sites List in 6kj8
Zinc binding site 3 out
of 3 in the E. Coli Atcase Holoenzyme Mutant - G166P (Catalytic Chain)
Mono view Stereo pair view
Reference:
Z.Lei,
B.Wang,
Z.Lu,
N.Wang,
H.Tan,
J.Zheng,
Z.Jia.
New Regulatory Mechanism-Based Inhibitors of Aspartate Transcarbamoylase For Potential Anticancer Drug Development. Febs J. 2020.
Page generated: Tue Oct 29 01:47:04 2024
ISSN: ISSN 1742-464X PubMed: 31967710 DOI: 10.1111/FEBS.15220 |
Last articlesZn in 9JYWZn in 9IR4 Zn in 9IR3 Zn in 9GMX Zn in 9GMW Zn in 9JEJ Zn in 9ERF Zn in 9ERE Zn in 9EGV Zn in 9EGW |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |